{
    "2018-02-06": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Centene (CNC) Beats Q4 Earnings & Revenues, Ups '18 View",
                "features": {
                    "keywords": [
                        "Centene",
                        "Q4 Earnings",
                        "Revenues",
                        "Ups '18 View"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "3 Top-Rated Dividend Aristocrats For 2018",
                "features": {
                    "keywords": [
                        "Top-Rated",
                        "Dividend Aristocrats",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-10",
                "original_text": "Reading into Abbott Laboratories’ Valuation",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "Valuation"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-20",
                "original_text": "Understanding Abbott Laboratories’ Latest 2018 Guidance",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "Latest 2018 Guidance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}